JANUS HENDERSON GROUP PLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$98,630,000
-56.7%
454,725
-77.0%
0.04%
-57.5%
Q4 2020$227,967,000
+14.7%
1,975,301
-3.2%
0.11%
+1.9%
Q3 2020$198,725,000
-5.9%
2,041,289
+18.6%
0.10%
-12.6%
Q2 2020$211,241,000
+40.2%
1,721,317
+0.1%
0.12%
+14.4%
Q1 2020$150,652,000
+58.9%
1,720,352
+89.7%
0.10%
+112.2%
Q4 2019$94,828,000
+78.0%
906,924
+95.9%
0.05%
+69.0%
Q3 2019$53,261,000
-33.4%
463,016
-0.1%
0.03%
-32.6%
Q2 2019$79,914,000
-12.7%
463,564
-14.6%
0.04%
-15.7%
Q1 2019$91,498,000
+65.2%
542,790
-4.5%
0.05%
+45.7%
Q4 2018$55,382,000
-46.0%
568,659
-4.2%
0.04%
-36.4%
Q3 2018$102,520,000
+6.9%
593,495
-13.6%
0.06%0.0%
Q2 2018$95,858,000
+18.8%
686,955
-4.1%
0.06%
+14.6%
Q1 2018$80,667,000
-22.5%
715,954
-9.2%
0.05%
-25.0%
Q4 2017$104,101,000
+42.9%
788,583
+9.9%
0.06%
+36.2%
Q3 2017$72,842,000
+3.9%
717,729
+2.6%
0.05%
-2.1%
Q2 2017$70,128,000699,5350.05%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders